indomethacin has been researched along with Atheroma in 2 studies
Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Inflammation is the main driver of the aggravation of arteriosclerosis, and the complex inflammatory response in plaque is usually the result of the interaction of various cells and cytokines." | 1.72 | Programmed prodrug breaking the feedback regulation of P-selectin in plaque inflammation for atherosclerotic therapy. ( Duan, Y; Gong, K; Guo, Q; Jing, H; Li, Z; Lin, J; Tian, Y; Wang, L; Wang, Q; Wu, Z; Yang, X, 2022) |
| "The decreased stability of atherosclerotic plaques increases the risk of ischemic stroke." | 1.72 | Identification of immune cell infiltration and diagnostic biomarkers in unstable atherosclerotic plaques by integrated bioinformatics analysis and machine learning. ( Kang, Z; Li, Z; Liu, J; Liu, Y; Wang, J, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, Q | 1 |
| Jing, H | 1 |
| Lin, J | 1 |
| Wu, Z | 1 |
| Tian, Y | 1 |
| Gong, K | 1 |
| Guo, Q | 1 |
| Yang, X | 1 |
| Wang, L | 1 |
| Li, Z | 2 |
| Duan, Y | 1 |
| Wang, J | 1 |
| Kang, Z | 1 |
| Liu, Y | 2 |
| Liu, J | 1 |
2 other studies available for indomethacin and Atheroma
| Article | Year |
|---|---|
Programmed prodrug breaking the feedback regulation of P-selectin in plaque inflammation for atherosclerotic therapy.
Topics: Animals; Atherosclerosis; Endothelial Cells; Feedback; Heparin, Low-Molecular-Weight; Indomethacin; | 2022 |
Identification of immune cell infiltration and diagnostic biomarkers in unstable atherosclerotic plaques by integrated bioinformatics analysis and machine learning.
Topics: Apolipoproteins E; Biomarkers; CD8-Positive T-Lymphocytes; Computational Biology; Fatty Acid-Binding | 2022 |